Descriptor English: | Etodolac | ||||||
Descriptor Spanish: |
Etodolaco
| ||||||
Descriptor Portuguese: | Etodolac | ||||||
Descriptor French: | Étodolac | ||||||
Entry term(s): |
AY 24,236 AY 24236 AY-24,236 AY-24236 Etodolac, (+-)-Isomer Etodolac, (-)-Isomer Etodolac, (S)-Isomer Etodolac, Monosodium Salt Etodolac, Monosodium Salt, (+-) Isomer Etodolac, Monosodium Salt, (S)-Isomer Etodolic Acid Lodine Ramodar Ultradol |
||||||
Tree number(s): |
D03.066.288.200 D03.633.100.473.404.200 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017308 | ||||||
Scope note: | A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE). |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Inflammatory Agents, Non-Steroidal Cyclooxygenase 2 Inhibitors |
||||||
Registry Number: | 2M36281008 | ||||||
CAS Type 1 Name: | Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro- | ||||||
Previous Indexing: |
Acetic Acids (1976-1988) Indoleacetic Acids (1976-1992) |
||||||
Public MeSH Note: | 1993; ETODOLAC was indexed under INDOLEACETIC ACIDS 1989-1992 and 1976-79, and under ACETIC ACIDS 1976-1988 |
||||||
History Note: | 1993 (1976) |
||||||
DeCS ID: | 30734 | ||||||
Unique ID: | D017308 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1993/01/01 | ||||||
Date of Entry: | 1992/05/08 | ||||||
Revision Date: | 2018/04/10 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Etodolac
- Preferred
Etodolac, (+-)-Isomer
- Narrower
Etodolac, (-)-Isomer
- Narrower
Etodolac, (S)-Isomer
- Narrower
Ultradol
- Narrower
Etodolac, Monosodium Salt, (+-) Isomer
- Narrower
Etodolac, Monosodium Salt, (S)-Isomer
- Narrower
Lodine
- Narrower
Ramodar
- Narrower
AY-24,236
- Narrower
Etodolac, Monosodium Salt
- Narrower
Concept UI |
M0026281 |
Scope note | A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE). |
Preferred term | Etodolac |
Entry term(s) |
Etodolic Acid |
Concept UI |
M0329289 |
Preferred term | Etodolac, (+-)-Isomer |
Concept UI |
M0329290 |
Preferred term | Etodolac, (-)-Isomer |
Concept UI |
M0329291 |
Preferred term | Etodolac, (S)-Isomer |
Concept UI |
M0352581 |
Preferred term | Ultradol |
Concept UI |
M0329287 |
Preferred term | Etodolac, Monosodium Salt, (+-) Isomer |
Concept UI |
M0329288 |
Preferred term | Etodolac, Monosodium Salt, (S)-Isomer |
Concept UI |
M0026282 |
Preferred term | Lodine |
Concept UI |
M0352580 |
Preferred term | Ramodar |
Concept UI |
M0352534 |
Preferred term | AY-24,236 |
Entry term(s) |
AY 24,236 AY 24236 AY-24236 |
Concept UI |
M0329286 |
Preferred term | Etodolac, Monosodium Salt |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey